Eli Lilly and Company, Berry Global Group, and Thermo Fisher Scientific are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are equity shares of companies engaged in the research, development, manufacturing and marketing of prescription drugs and medical therapies. Their performance is often driven by factors such as clinical trial results, regulatory approvals, patent expirations and healthcare policy changes. Investors monitor these stocks closely for breakthroughs in treatments as well as potential risks from pricing pressures and competitive innovation. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE:LLY traded up $2.18 during trading on Monday, reaching $825.80. The company had a trading volume of 1,765,159 shares, compared to its average volume of 3,471,086. The firm has a market capitalization of $782.99 billion, a PE ratio of 70.55, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. Eli Lilly and Company has a twelve month low of $677.09 and a twelve month high of $972.53. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The firm's fifty day moving average is $825.36 and its 200 day moving average is $814.96.
Read Our Latest Research Report on LLY
Berry Global Group (BERY)
Berry Global Group, Inc. manufactures and supplies non-woven, flexible, and rigid products in consumer and industrial end markets in the United States, Canada, Europe, and internationally. The company operates through Consumer Packaging International; Consumer Packaging North America; Engineered Materials; and Health, Hygiene & Specialties segments.
NYSE BERY traded down $1.94 during trading on Monday, hitting $67.69. 18,809,857 shares of the company traded hands, compared to its average volume of 1,400,205. The business has a fifty day simple moving average of $68.84 and a 200 day simple moving average of $68.56. The company has a current ratio of 1.61, a quick ratio of 1.09 and a debt-to-equity ratio of 3.35. The company has a market capitalization of $7.84 billion, a P/E ratio of 16.88, a PEG ratio of 1.54 and a beta of 1.14. Berry Global Group has a 12 month low of $57.52 and a 12 month high of $74.24.
Read Our Latest Research Report on BERY
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of NYSE:TMO traded up $0.36 during trading on Monday, hitting $423.91. 1,398,240 shares of the company's stock were exchanged, compared to its average volume of 1,767,996. The firm has a market cap of $160.02 billion, a P/E ratio of 25.65, a PEG ratio of 2.99 and a beta of 0.86. The firm has a 50-day moving average price of $476.15 and a two-hundred day moving average price of $520.61. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. Thermo Fisher Scientific has a 1-year low of $409.85 and a 1-year high of $627.88.
Read Our Latest Research Report on TMO
Featured Articles
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
